$MNTS Cashflow Statement | Understand Stock

$MNTS

$2.15 +$0.03 (1.42%) Pre-market

$MNTS Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated statements of cash flows

In millions of USD, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
Cash flows from operating activities:
Net loss
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization
Amortization of debt (premium) and issuance costs
Amortization of right-of-use assets
Decrease in fair value of SAFE notes
Impairment of prepaid launch costs
Write-off of deferred offering costs
Litigation settlement, net
Other Litigation Settlements
Total litigation settlement, net
Change in fair value of convertible debt carried at fair value
Change in fair value of the Credit Provision Derivative
Impairment of prepaid services
Loss on disposal of fixed and intangible assets
Debt issuance costs expensed for convertible debt carried at fair value
Loss on debt extinguishment
Loss on issuance of warrant liabilities
Stock-based compensation expense
Issuance of common stock for consulting services
Issuance of convertible notes for legal services
Changes in operating assets and liabilities:
Accounts receivable
Prepaids and other current assets
Insurance receivable
Other non-current assets
Accounts payable
Accrued liabilities
Accrued interest
Other current liabilities
Contract liabilities
Lease liabilities and right-of-use assets
Operating lease liability
Litigation settlement contingency
Other non-current liabilities

Net cash used in operating activities
Cash flows from investing activities:
Purchases of property, machinery and equipment
Proceeds from sale of property, machinery and equipment
Purchases of intangible assets
Net cash (used in) provided by investing activities
Cash flows from financing activities:
Proceeds from issuance of SAFE notes
Proceeds from issuance of convertible notes and warrants
Payment of convertible notes
Proceeds from issuance of loan payable
Proceeds from issuance of related party notes
Principal payments on related party notes
Principal payments on loan payable
Payment of deferred offering costs
Payment of debt issuance costs
Payment of warrant issuance costs
Proceeds from exercise of stock options
Payment for repurchase of Section 16 Officer common shares for tax coverage exchange
Proceeds from employee stock purchase plan
Payments for issuance costs related to exercise of warrants
Repurchase of Section 16 Officer shares for tax coverage exchange
Payment for repurchase of common shares
Payments of issuances costs related to PIPE
Net cash provided by financing activities

Increase (Decrease) in cash, cash equivalents, and restricted cash
Cash, cash equivalents, and restricted cash, beginning of period
Cash, cash equivalents, and restricted cash, end of period
Issuance of common stock related to conversion of SAFE notes
Issuance of common stock related to exercise of warrant liabilities
Reclassification of deferred offering costs
Deferred offering costs in accounts payable and accrued expenses at period end
Assumption of merger warrants liability
Operating lease right-of-use assets in exchange for lease obligations
Purchases of property, machinery and equipment in accounts payable and accrued expenses at period end
Purchases of intangible assets in accounts payable and accrued expenses at year end
Issuance costs related to warrant modification
Stock repurchase liability fair value
Cash paid for income taxes
Cash paid for interest

Comments